Immunocytochemical evidence that glutamate is a neurotransmitter in the cochlear nerve: a quantitative study in the guinea-pig anteroventral cochlear nucleus.
The large so-called type I afferents of the cochlear nerve carry the majority of the auditory input from the cochlea to the cochlear nuclei in the brainstem. These fibres are excitatory and previous studies have suggested they may use glutamate as their neurotransmitter. In the present investigation therefore, antibodies to glutamate and to the glutamate precursor, glutamine, were applied to resin sections of perfusion-fixed brains and of in vitro brain slices subjected to depolarizing levels of potassium before fixation to study glutamate handling and synaptic release. Ultrathin sections were labelled by the immunogold technique, and the immunoreactivity was quantified by recording the density of gold particles over the various tissue profiles. Non-primary, presumably inhibitory, terminals and glial processes were used as reference structures. The cochlear primary terminals proved to be strongly immunoreactive for glutamate. The density of glutamate labelling was higher in primary terminals than in non-primary ones, and lowest in glial processes. The ratio between the mean glutamate and glutamine labelling densities was also higher in primary terminals than in non-primary ones, and lowest in glial processes in each case. In the primary terminals, the glutamate immunoreactivity was higher over vesicle-containing regions than over vesicle-free regions, whilst glutamine was evenly distributed throughout. The in vitro brain slices showed a potassium-induced, partly calcium-dependent depletion of glutamate from the primary terminals but not from the non-primary ones. These observations strongly support the conclusion that glutamate is a neurotransmitter of type I cochlear afferents.
Hackney
C M
CM
Department of Communication and Neuroscience, Keele University, Staffordshire, UK.
Osen
K K
KK
Ottersen
O P
OP
Storm-Mathisen
J
J
Manjaly
G
G
D000344:Afferent Pathways / Q000502:physiology; D000818:Animals; D000906:Antibodies; D001933:Brain Stem / Q000502:physiology; D003056:Cochlear Nerve / Q000166:cytology / Q000502:physiology*; D018846:Excitatory Amino Acids / Q000032:analysis*; D018698:Glutamic Acid / Q000032:analysis / Q000502:physiology*; D005973:Glutamine / Q000032:analysis / Q000502:physiology; D006168:Guinea Pigs; D007150:Immunohistochemistry / Q000379:methods; D066298:In Vitro Techniques; D008854:Microscopy, Electron; D016253:Microscopy, Immunoelectron; D009412:Nerve Fibers / Q000502:physiology / Q000648:ultrastructure; D009474:Neurons / Q000166:cytology / Q000502:physiology* / Q000648:ultrastructure; D018377:Neurotransmitter Agents / Q000032:analysis / Q000502:physiology*; D013569:Synapses / Q000502:physiology* / Q000648:ultrastructure
D000906:Antibodies; D018846:Excitatory Amino Acids; D018377:Neurotransmitter Agents; D005973:Glutamine; D018698:Glutamic Acid